1Boyle P, Robertson C, Mazzetta C, et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int, 2003, 92(4):409.
2McConnell J D. Benign prostatic hyperplasia: treatment guidelines and patient classification. Br J Urol,1995, 76(Suppl 1):29.
5Azadzoi K M, Tarcan T, Siroky M B, et al. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit.J Urol,1999,161(5):1626.
6Nakai H, Yamanishi T, Yasuda K, et al. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia. Neurourol Urodyn, 2004,23(7):618.
7Abrams P. Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology,2003,62(5 Suppl 2):28.
8Knutson T, Edlund C, Fall M, et al. BPH with coexisting overactive bladder dysfunction-an everyday urological dilemma. Neurourol Urodyn, 2001,20(3):237.
9Hampel C, Dolber P C, Smith M P, et al. Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction. J Urol, 2002,167(3):1513.
10Kuo H C. Analysis of the pathophysiology of lower urinary tract symptoms in patients after prostatectomy. Urol Int, 2002,68(2):99?A?A.
7Nickel JC, Downey J, Young I, et al. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia[ J ]. BJU Int, 1999, 84(9) : 976 -80.
8Nickel JC, True LD, Krieger JN, et al. Consensus development of a histopathological classification system for chronic prostatic inflammation[J]. BJU Int, 2001, 87(9): 797- 805.
9Armitage J, Emberton M. Is it time to reconsider the role of prostatic inflammation in the pathogenesis of bower urinary tract symptoms[J]. BJU Int, 2005, 96 (6) : 745 -746.
10Roehrbom CG, Kaplan SA, Noble WD, et al. The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study.2005 AUA meeting[J]. J Urol, 2005,173 (Suppl 4) : 346.
